We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.3B
AUM Growth
-$1.95B
Cap. Flow
-$2.03B
Cap. Flow %
-16.47%
Top 10 Hldgs %
23.48%
Holding
1,965
New
109
Increased
648
Reduced
914
Closed
286

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$24.9M
2
PLTR icon
Palantir
PLTR
+$24.7M
3
APP icon
Applovin
APP
+$16.8M
4
MSTR icon
Strategy Inc
MSTR
+$12.4M
5
HD icon
Home Depot
HD
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 28.64%
2 Consumer Discretionary 9.28%
3 Healthcare 7.92%
4 Communication Services 7.89%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGS
1601
DELISTED
PlayAGS
AGS
$190K ﹤0.01%
16,499
-211
-1% -$2.44K
CERT icon
1602
Certara
CERT
$1.25B
$189K ﹤0.01%
17,760
-186,308
-91% -$2.02M
XP icon
1603
XP
XP
$8.39B
$188K ﹤0.01%
15,850
+4,530
+40% +$71.3K
STNE icon
1604
StoneCo
STNE
$2.58B
$187K ﹤0.01%
23,403
+3,322
+17% +$33.7K
HBM icon
1605
Hudbay
HBM
$12.3B
$186K ﹤0.01%
+23,003
New +$206K
MATV icon
1606
Mativ Holdings
MATV
$711M
$183K ﹤0.01%
+16,795
New +$234K
NWG icon
1607
NatWest
NWG
$76.4B
$178K ﹤0.01%
17,516
+5,116
+41% +$50.6K
IGR
1608
CBRE Global Real Estate Income Fund
IGR
$713M
$178K ﹤0.01%
+37,000
New +$210K
RVNC
1609
DELISTED
Revance Therapeutics, Inc.
RVNC
$177K ﹤0.01%
58,303
-569
-1% -$2.48K
TWI icon
1610
Titan International
TWI
$475M
$177K ﹤0.01%
+26,088
New +$188K
ENLC
1611
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$176K ﹤0.01%
12,434
-43
-0.3% -$641
SSYS icon
1612
Stratasys
SSYS
$774M
$172K ﹤0.01%
19,300
-5,762
-23% -$49.6K
NIO icon
1613
NIO
NIO
$11.9B
$170K ﹤0.01%
38,888
+6,395
+20% +$32.5K
ACH
1614
Accendra Health
ACH
$214M
$166K ﹤0.01%
+12,739
New +$170K
MFG icon
1615
Mizuho Financial
MFG
$130B
$165K ﹤0.01%
33,837
+11,729
+53% +$54.1K
NVRI icon
1616
Enviri
NVRI
$620M
$164K ﹤0.01%
21,359
-2,047
-9% -$17.1K
GOGL
1617
DELISTED
Golden Ocean Group
GOGL
$164K ﹤0.01%
+18,348
New +$198K
CWK icon
1618
Cushman & Wakefield Ltd
CWK
$3.25B
$164K ﹤0.01%
12,547
-11,174
-47% -$155K
UEC icon
1619
Uranium Energy
UEC
$5.57B
$163K ﹤0.01%
24,399
-7,306
-23% -$55.9K
AHCO icon
1620
AdaptHealth
AHCO
$759M
$158K ﹤0.01%
16,613
+1,525
+10% +$15.4K
SNDX icon
1621
Syndax Pharmaceuticals
SNDX
$1.82B
$157K ﹤0.01%
+11,881
New +$203K
DRH icon
1622
Diamondrock Hospitality Co
DRH
$2.56B
$156K ﹤0.01%
17,308
-1,889
-10% -$17.2K
SHO icon
1623
Sunstone Hotel Investors
SHO
$2.06B
$156K ﹤0.01%
13,185
-38,432
-74% -$419K
SBLK icon
1624
Star Bulk Carriers
SBLK
$3.22B
$155K ﹤0.01%
+10,377
New +$193K
GRAB icon
1625
Grab
GRAB
$14.9B
$155K ﹤0.01%
32,784
-13,807
-30% -$62.8K

Similar funds

Guggenheim Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Guggenheim Capital held 1,965 positions worth $12.3B, down 14% from $14.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Guggenheim Capital withdrew a net $2.03B in Q4 2024, closing 286 positions and reducing 914 holdings. Its most notable exit was MGP Ingredients, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Guggenheim Capital opened a new position in iShares Core S&P 500 ETF worth $24.8M.

  • Guggenheim Capital's largest Q4 2024 buy was iShares Core S&P 500 ETF: 42,150 shares worth $24.8M.
  • Guggenheim Capital added most to Palantir in Q4 2024, an estimated $24.7M increase.
  • Guggenheim Capital's biggest Q4 2024 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $183M.
  • Guggenheim Capital fully exited MGP Ingredients in Q4 2024, selling an estimated $13.5M.
  • Guggenheim Capital's ten largest holdings make up 23% of its $12.3B portfolio in Q4 2024.
  • Guggenheim Capital opened 109 new positions and closed 286 in Q4 2024.
  • Guggenheim Capital's portfolio value fell 14% quarter-over-quarter to $12.3B.

Based on Guggenheim Capital's 13F filing for Q4 2024, filed 13 Feb 2025.